
Japan's takeda aims to grow in spain
Catalan Economy
01 Mar 2010
Japanese pharmaceutical company takeda aims at strengthening its position in spain with the creation of a new subsidiary in barcelona. the japanese group will initially market its drugs for hypertension and diabetes. in the coming months, takeda also plans to launch a new treatment for osteosarcoma, which will represent a significant development in the field of cancer treatments in spain.
takeda is the largest pharmaceutical company in japan and one of the world's 20 largest pharmaceutical companies. its european operations include germany, switzerland, austria, france, britain, italy and spain. catalan agency acc1ó and its invest in catalonia unit offered advise throughout the operation.
source: la vanguardia 25/02/2010
Related News and Success stories.
-
11 Jun 2025
Barcelona-based SpliceBio secures a €118 million financing round for advancing in gene therapy
-
11 Jun 2025
Catalonia targets Asian markets with first wine trade mission to China and Taiwan
-
06 Jun 2025
Barcelona chosen as UNESCO's global hub for the sustainable Blue Economy
-
29 May 2025
University of Barcelona Science Park consolidates growth with €124 million in investment in 2024